Skip Navigation


NDT Advance Access originally published online on January 16, 2008
Nephrology Dialysis Transplantation 2008 23(5):1773-1774; doi:10.1093/ndt/gfm930
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/5/1773-a    most recent
gfm930v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Keven, K.
Right arrow Articles by Sengul, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keven, K.
Right arrow Articles by Sengul, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



ABO-incompatible kidney transplantation: on-demand strategy

Correspondence and offprint requests to: E-mail: keven{at}medicine.ankara.edu.tr

Sir,

We read with great interest the recent article by Wilpert et al., on the alternative strategy to scheduled post-transplant immunoadsorptions after ABO-incompatible renal transplantation [1]. After giving rituximab 4 weeks prior to scheduled transplantation, a triple immunosuppression regimen was started and antigen-specific immunoadsorptions were performed, until IgG-anti-A/B titers equalled 1:4 or less on the morning of transplantation. Wilpert et al. did not routinely perform immunoadsorption, unless antibody titers exceed pre-defined thresholds after transplantation. With this approach, 15 of 22 patients did not require post-operative immunoadsorption (post-tx IA). They concluded that immunoadsorbtion can be performed according to post-operative antibody titers in ABO-incompatible kidney transplantation.

In Table 2, there were three and five patients of living-related kidney transplantation in patients with post-tx IA and without post-tx IA, respectively. Were the rest of the patients living-unrelated kidney recipients? How many spouses, emotionally related or non-directed donors were there? Who covered the cost of these transplantations? Was there any analysis comparing the costs of ABO-mismatch and -match transplantation in this centre? The average dialysis time was 44 ± 32 months before the transplantation. Why is the duration of waiting in dialysis this long while there are living donors? Also, we noticed that 17 months after transplantation, the mean estimated glomerular filtration rates (eGFRs) (not creatinine-clearance) were 50 ml/min/1.73 m2 (MDRD formula) in patients requiring post-tx IA and 46 ml/min/1.73 m2 in patients without post-tx IA (Table 2). These are the mean levels; however, considering the number of patients, median levels should have been given with minimum and maximum levels. When looking at the median levels, eGFRs were 53  ml/min/1.73 m2 in post-tx IA and 45 ml/min/1.73 m2 in non-post-tx IA group. In this study, eGFR seems to be lower in both groups when compared with large study samples [2].

Conflict of interest statement. None declared.

Kenan Keven and Sule Sengul

Department of Nephrology, Ankara University School of Medicine, Ankara, Turkey

References

  1. Wilpert J, Geyer M, Pisarski P, et al. On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation. Nephrol Dial Transplant (2007) 22:3048–3051.[Abstract/Free Full Text]
  2. Ulrich F, Daloze P, Vitko S, et al. Characterisation of acute rejections and associated relative risk factors in the Symphony study. Transpl Int (2007) 20(Suppl_2):19.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/5/1773-a    most recent
gfm930v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Keven, K.
Right arrow Articles by Sengul, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keven, K.
Right arrow Articles by Sengul, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?